RELSYMPLA
DEAD

Serial Number

79384282

Owner

AIC316 GmbH

Filing Date

Oct 30, 2023

Add to watchlist:

No watchlists yet
View on USPTO

RELSYMPLA Trademark

Serial Number: 79384282

RELSYMPLA is a trademark filed by AIC316 GmbH on October 30, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

AIC316 GmbH (7 trademarks)

Friedrich-Ebert-Str. 475

Entity Type: 98

Trademark Details

Filing Date

October 30, 2023

Registration Date

Not Registered

Goods & Services

Organization of seminars and conventions in the field of medicine; publication of scientific information journals; providing online electronic publications; providing electronic publications; courses (training -) relating to science; organization of seminars and conventions in the field of virology

Medical devices for intra-vaginal use; devices for intra-vaginal application of anti-virals; devices for intra-vaginal application of sulfonamides

Anti-viral agents; anti-viral agents for topical use; medicine; medicines for human purposes; medicines for veterinary purposes; medicines for dental purposes; eye lotions for medical use; eye ointment for medical use; creams for dermatological use; dermatological-pharmaceutical products; dermatological preparations; medicated lip creams; therapeutic creams [medical]; medicated skin creams; medicated skin lotions; medicinal preparations for the treatment of infectious diseases; medicated ointments for application to the skin; medicated preparations for skin treatment; medicated ointments for treating dermatological conditions; preparations for the treatment of herpes of the lips; ophthalmological preparations; ophthalmic preparations; ophthalmologic preparations; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for use in ophthalmology; pharmaceutical products for ophthalmological use; topical ophthalmic anti-infective substances for the treatment of infections; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical lip ointments; pharmaceutical preparations for use in dermatology; pharmaceutical preparations and substances for use in gynecology; pharmaceutical preparations and substances for use in urology; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of diseases of the genitourinary system; pharmaceutical preparations for the prevention of diseases of the genitourinary system; pharmaceutical preparations for skin wounds; sulfonamides [medicines]; sulfonamide preparations; transdermal patches for medical treatment; pharmaceutical lipsalves; antiviral drugs for treating HSV (Herpes Simplex Virus); preparations for the treatment of genital herpes; medicinal preparations for the treatment of HSV (Herpes Simplex Virus); preparations for the treatment of labial herpes; preparations for the treatment of mucosal herpes; pharmaceutical preparations for the treatment of HSV (Herpes Simplex Virus) infections; pharmaceutical preparations for skin lesions; sulfonamides [salts thereof]; pharmaceutical formulations in the form of tablets; pharmaceutical formulations in the form of solutions; pharmaceutical formulations in the form of suspensions; pharmaceutical formulations for intra-veneous application; antiviral drugs for treating of sexually transmittable diseases; medicinal preparations for the treatment of sexually transmittable diseases

Pharmaceutical services; consultancy and information services relating to medical products; providing health information; information relating to health; provision of health information; medical information services provided via the internet

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Mar 12, 2026 NREP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 17, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 29, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 29, 2025 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 23, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 23, 2024 ABN2
REFUSAL PROCESSED BY IB
Jan 23, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 30, 2023 RFCS
REFUSAL PROCESSED BY MPU
Dec 30, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 20, 2023 RFCR
NON-FINAL ACTION WRITTEN
Dec 19, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 19, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 5, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 1, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 30, 2023 REPR